"
Team:Goettingen/project overview/project
From 2014.igem.org
m |
m |
||
| Line 47: | Line 47: | ||
</div> | </div> | ||
| + | <script>var url1 = "https://2014.igem.org/Team:Goettingen/project_overview"; | ||
| + | var url2="https://2014.igem.org/Team:Goettingen/project_overview/fungal_infections"; | ||
| + | var url3="https://2014.igem.org/Team:Goettingen/project_overview/current_tools"; | ||
| + | var url4="https://2014.igem.org/Team:Goettingen/project_overview/project"; | ||
| + | var url5="https://2014.igem.org/Team:Goettingen/project_overview/perspectives"; | ||
| + | var url6="https://2014.igem.org/Team:Goettingen/project_overview/diganosis"; | ||
| + | var url7="https://2014.igem.org/Team:Goettingen/project_overview/therapeutics";</script> | ||
| + | <script>$(document).keydown(function(e) { | ||
| + | switch(e.which) { | ||
| + | case 37: // left | ||
| + | window.location = url3; | ||
| + | break; | ||
| + | |||
| + | |||
| + | case 39: // right | ||
| + | console.log("right"); | ||
| + | window.location = url5; | ||
| + | break; | ||
| + | |||
| + | |||
| + | |||
| + | default: return; // exit this handler for other keys | ||
| + | } | ||
| + | e.preventDefault(); // prevent the default action (scroll / move caret) | ||
| + | });</script> | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 09:51, 8 September 2014
Project
4/7 
Our project!
Paving the way for new diagnostic and therapeutic tools
Our aim is to develop a diagnostic technique capable of detecting the presence of fungal pathogens in a sample collected from a patient. Briefly, our approach is as follows. Through a yeast two-hybrid assay we will select a set of peptides that show affinity towards surface proteins from different fungi (Aspergillus nidulans, A. fumigatus, Candida albicans and C. glabrata). After confirming the interaction between the surface proteins and a given peptide, we intend to attach a molecule to the peptide marker. In our project, this molecule will be a fluorescent protein, but in principle can also be an immune system activator which is then recognized by the immune cells or other chemical moiety that adds novel functionalities or increases the peptide stability. In comparison to antibodies or antibody fragments, peptides are small, easily synthesized, modified less expensively and show higher diffusion rates in tissues. We expect our method to be faster, more accurate and cheaper than other existing methods. Other laboratories may follow our approach to generate and refine their own peptides with specificity towards their proteins of interest.
